SCHEMBL23770693

SCHEMBL23770693

Cc1cccc(C(F)(F)F)c1-c1nc(NSc2cccc(N)n2)ccc1Cl

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.30
MPL P40238 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770549 0.91 ABL1 (0.32) MPL
SCHEMBL23770602 0.89 NOS3 (0.33)
SCHEMBL23770550 0.87 NOS3 (0.31)
SCHEMBL23770542 0.86 MPL (0.34) PTPN1MPL
SCHEMBL23770417 0.86 GAA (0.33)
SCHEMBL23770405 0.85 PTPN1 (0.31) PTPN1MPL
SCHEMBL23770756 0.85 BACE1 (0.36) PTPN1MPL
SCHEMBL23770546 0.84
SCHEMBL23770406 0.83 NOS3 (0.30)
SCHEMBL23770644 0.83 NOS3 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed